Cerus | CERS - Operating Profit

Stock Price
2.08
Daily Change
0.08 4.00%
Monthly
15.56%
Yearly
61.24%
Q2 Forecast
2.03

Cerus reported $-1.45M in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
Cerus USD -1.45M 488K Dec/2024
GRIFOLS EUR 275.38M 76.74M Dec/2025
Haemonetics USD 67.4M 8.9M Dec/2025
Neogen USD -3.3M 2.08M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Plus Therapeutics USD -5.74M 1.26M Dec/2025
Quidel USD -37.3M 667.5M Dec/2025
Rockwell Medical USD 515K 1.84M Jun/2024
STAAR Surgical USD -10.93M 29.42M Dec/2025
Terumo JPY 43.88B 1.21B Dec/2025
Utah Medical Products USD 2.44M 1.32M Dec/2025